Catch up on the top radiology news of the past week.

The Pulmonary Embolism (PE) Triage and Notification (PETN) module with RapidAI’s RapidPE platform reportedly demonstrated over 90 percent sensitivity and specificity rates for detection of central PE on computed tomography (CT), according to multicenter study findings presented at the 9th Annual Pulmonary Embolism Symposium.

New research suggests the capability of a mammography-based deep learning model to identify women at high risk of breast cancer led to more than triple the cancer detection rate on breast MRI in comparison to traditional risk assessment tools.

In a study of over 300 patients, researchers saw no significant differences in upgrading or downgrading of prostate cancer assessment on MRI with PI-RADS 2.1 in comparison to PI-RADS 2.0

For cT1 renal masses < 4 cm and renal masses < 2 cm, the PET/CT agent 89Zr-DFO-girentuximab had respective sensitivity rates of approximately 85 percent and 96.7 percent for diagnosing clear cell renal cell carcinoma, according to research recently presented at the European Association of Nuclear Medicine (EANM) 2023 Congress.

The artificial intelligence (AI)-enabled AIRAscore can reportedly provide quantitative brain volume data within five minutes of assessing brain MRI scans.

The use of automated detection of large vessel occlusion on computed tomography (CT) through artificial intelligence (AI) software reportedly led to an 11.2-minute reduction in triage time from the completion of imaging to initiation of endovascular therapy, according to newly published research.

Review the case study and test your knowledge to make the correct diagnosis.

Twice-a-day consumption of reconstituted grape powder provides significant long-term benefit in preserving cerebral metabolism for people with mild cognitive decline, according to research presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

Over 80 percent of head and neck computed tomography angiography (CTA) exams performed in the emergency department had no actionable findings for patients with non-focal neurologic complaints, and 67 percent of the exams were ordered by non-physician practitioners (NPPs), according to a newly published study.

While this author has no intention of retiring from radiology, he notes that retiring from certain work schedules or aspects of the field have had a favorable impact on his life.

Catch up on the top radiology content of the past week.

In a recent interview, Sophia Rose O’Brien, M.D., shared her insights on the roles and limitations of FDG PET/CT and FES PET/CT in the imaging of patients with metastatic breast cancer.

In a recent video interview, Vivek Bansal, M.D., discussed a recent Radiology Partners publication that offers practical tips and best practice guidance on CT and MRI neuroimaging for stroke patients.

A robotic guidance and placement system, the IGAR system can be utilized inside of a magnetic resonance imaging (MRI) bore.

For men with PSA scores between 4 to 10 ng/mL, a multivariate prediction model that incorporates 68Ga-PSMA PET/CT had a 92.7 AUC for predicting clinically significant prostate cancer, according to newly published research.

Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.

Abnormal findings on coronary computed tomography angiography-derived fractional flow reserve (CCTA-FFR) are associated with 3.2-fold higher risks of all-cause death or spontaneous myocardial infarction (MI) in patients with new-onset stable angina pectoris and coronary stenosis, according to newly published research.

Review the case study and test your knowledge to make the correct diagnosis.

The Precision GI™ Endoscopic Ultrasound Biopsy Device reportedly provides a more efficient and less traumatic method of obtaining biopsy tissue for suspected gastrointestinal cancers.